global819098k.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) 
August 19, 2009

GLOBAL MED TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)

Colorado 0-22083 84-1116894
(State or other jurisdiction of (Commission File No.) (I.R.S. Employer
incorporation) Identification No.)
                                                   
12600 West Colfax, Suite C-420, Lakewood, Colorado 80215
(Address of principal executive offices) (Zip Code)
                                     
(303) 238-2000
(Registrant’s telephone number, including area code)

              
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the 
registrant under any of the following provisions: 
                            
¨   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 


Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers.


     On August 19, 2009, Karen B. Davis informed Global Med Technologies, Inc. (the “Company”) that she intends to resign from her position as Chief Financial Officer of the Company effective as of September 18, 2009.

 

 

 

 

 

 

- 2 -


SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

GLOBAL MED TECHNOLOGIES, INC.                             
               
        By:     /s/  Michael I. Ruxin, M.D. 
                   Michael I. Ruxin, M.D.
                   Chairman of the Board  and Chief Executive Officer         
 
Date:    August 25, 2009          

 

 

 

- 3 -